ERBIN
Basic information
Region (hg38): 5:65883128-66082546
Previous symbols: [ "ERBB2IP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (817 variants)
- ERBIN-related_disorder (59 variants)
- not_specified (18 variants)
- Prostate_cancer (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERBIN gene is commonly pathogenic or not. These statistics are base on transcript: NM_001253697.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 161 | 176 | ||||
missense | 472 | 13 | 493 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 11 | 11 | ||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 0 | 0 | 494 | 174 | 17 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERBIN | protein_coding | protein_coding | ENST00000506030 | 24 | 156075 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.994 | 0.00598 | 125723 | 0 | 25 | 125748 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.892 | 636 | 703 | 0.905 | 0.0000335 | 9392 |
Missense in Polyphen | 224 | 286.54 | 0.78175 | 3912 | ||
Synonymous | 0.0452 | 241 | 242 | 0.996 | 0.0000115 | 2613 |
Loss of Function | 6.30 | 12 | 68.1 | 0.176 | 0.00000384 | 858 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000165 | 0.000157 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000135 | 0.000132 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000104 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an adapter for the receptor ERBB2, in epithelia. By binding the unphosphorylated 'Tyr-1248' of receptor ERBB2, it may contribute to stabilize this unphosphorylated state (PubMed:16203728). Inhibits NOD2-dependent NF-kappa-B signaling and proinflammatory cytokine secretion (PubMed:16203728). {ECO:0000269|PubMed:10878805, ECO:0000269|PubMed:16203728}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Nucleotide-binding Oligomerization Domain (NOD) pathway;NLR Proteins;Pathways Affected in Adenoid Cystic Carcinoma;Signal Transduction;Alpha6Beta4Integrin;TCR;Downregulation of ERBB2 signaling;EGFR1;Signaling by ERBB2;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- rvis_EVS
- 1.39
- rvis_percentile_EVS
- 94.64
Haploinsufficiency Scores
- pHI
- 0.446
- hipred
- Y
- hipred_score
- 0.750
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Erbin
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein targeting;cell adhesion;signal transduction;epidermal growth factor receptor signaling pathway;integrin-mediated signaling pathway;negative regulation of NF-kappaB transcription factor activity;response to muramyl dipeptide;response to lipopolysaccharide;ERBB2 signaling pathway;intermediate filament cytoskeleton organization;basal protein localization;establishment or maintenance of epithelial cell apical/basal polarity;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;cellular response to tumor necrosis factor;negative regulation of monocyte chemotactic protein-1 production;regulation of postsynaptic membrane neurotransmitter receptor levels
- Cellular component
- basement membrane;nucleus;cytoplasm;plasma membrane;basal plasma membrane;basolateral plasma membrane;nuclear speck;cell junction;hemidesmosome;nuclear membrane;postsynapse;glutamatergic synapse
- Molecular function
- signaling receptor binding;ErbB-2 class receptor binding;structural constituent of cytoskeleton;protein binding